126 related articles for article (PubMed ID: 24510537)
1. RECK gene polymorphisms influence NSCLC susceptibility, but not the chemotherapy response status in Chinese cohort.
Chen X; Jiang F; Shi N; Zhou H; Zhang L; Chen Y; Zheng Y; Yan TG
Cell Biochem Biophys; 2014 Jul; 69(3):567-71. PubMed ID: 24510537
[TBL] [Abstract][Full Text] [Related]
2. Effect of RECK gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathologic features.
Chung TT; Yeh CB; Li YC; Su SC; Chien MH; Yang SF; Hsieh YH
PLoS One; 2012; 7(3):e33517. PubMed ID: 22428065
[TBL] [Abstract][Full Text] [Related]
3. Impact of RECK gene polymorphisms and environmental factors on oral cancer susceptibility and clinicopathologic characteristics in Taiwan.
Chung TT; Pan MS; Kuo CL; Wong RH; Lin CW; Chen MK; Yang SF
Carcinogenesis; 2011 Jul; 32(7):1063-8. PubMed ID: 21565829
[TBL] [Abstract][Full Text] [Related]
4. The role of NQO1 polymorphisms in the susceptibility and chemotherapy response of Chinese NSCLC patients.
Tian G; Wang M; Xu X
Cell Biochem Biophys; 2014 Jul; 69(3):475-9. PubMed ID: 24464627
[TBL] [Abstract][Full Text] [Related]
5. RECK Gene Promoter rs10814325 Polymorphism in Egyptian Patients with Hepatocellular Carcinoma on Top of Chronic Hepatitis C Viral Infection.
Fakhry AB; Ahmed AI; AbdelAlim MA; Ramadan DI
Asian Pac J Cancer Prev; 2016; 17(5):2383-8. PubMed ID: 27268601
[TBL] [Abstract][Full Text] [Related]
6. RECK Gene Polymorphism is Associated with Susceptibility and Prognosis of Wilms' Tumor in Chinese Children.
Yu Y; Hu Y; Li K; Chen Z; Zhang H; Zhang L
Med Sci Monit; 2015 Jul; 21():1928-33. PubMed ID: 26141647
[TBL] [Abstract][Full Text] [Related]
7. RECK Variants are Associated with Clinicopathological Features and Decreased Susceptibility in Mexican Patients with Colorectal Cancer.
María Márquez-González R; Margarita Saucedo-Sariñana A; Barros-Núñez P; Patricia Gallegos-Arreola M; Ibet Juárez-Vázquez C; Daniel Pineda-Razo T; Eugenia Marin-Contreras M; Esperanza Flores-Martínez S; Alejandra Rosales-Reynoso M
Tohoku J Exp Med; 2022 Jun; 257(2):163-169. PubMed ID: 35444107
[TBL] [Abstract][Full Text] [Related]
8. Effect of polymorphisms in XPD on clinical outcomes of platinum-based chemotherapy for Chinese non-small cell lung cancer patients.
Wu W; Li H; Wang H; Zhao X; Gao Z; Qiao R; Zhang W; Qian J; Wang J; Chen H; Wei Q; Han B; Lu D
PLoS One; 2012; 7(3):e33200. PubMed ID: 22479369
[TBL] [Abstract][Full Text] [Related]
9. Role of ERCC5 polymorphisms in non‑small cell lung cancer risk and responsiveness/toxicity to cisplatin‑based chemotherapy in the Chinese population.
Li M; Chen R; Ji B; Fan C; Wang G; Yue C; Jin G
Oncol Rep; 2021 Mar; 45(3):1295-1305. PubMed ID: 33469680
[TBL] [Abstract][Full Text] [Related]
10. Gene polymorphism of DNA repair gene X-ray repair cross complementing group 1 and xeroderma pigmentosum group D and environment interaction in non-small-cell lung cancer for Chinese nonsmoking female patients.
Wang L; Wang LL; Shang D; Yin SJ; Sun LL; Wang XY; Ji HB
Kaohsiung J Med Sci; 2019 Jan; 35(1):39-48. PubMed ID: 30844146
[TBL] [Abstract][Full Text] [Related]
11. FGFR4 genetic polymorphisms determine the chemotherapy response of Chinese patients with non-small cell lung cancer.
Fang HM; Tian G; Zhou LJ; Zhou HY; Fang YZ
Acta Pharmacol Sin; 2013 Apr; 34(4):549-54. PubMed ID: 23524567
[TBL] [Abstract][Full Text] [Related]
12. Tankyrase 1 polymorphism associated with an increased risk in developing non-small cell lung cancer in a Chinese population: a proof-of-principle study.
Wang Y; Jiang W; Liu X; Zhang Y
Int J Clin Exp Pathol; 2015; 8(9):10500-11. PubMed ID: 26617760
[TBL] [Abstract][Full Text] [Related]
13. Tag SNPs of CFI contributed to the susceptibility for non-small cell lung cancer in Chinese population.
Liu Y; Bi Y; Lin J; Cao L; He B; Zhang Z; Cui Y; Zhang X
Tumour Biol; 2015 Mar; 36(3):1955-62. PubMed ID: 25394898
[TBL] [Abstract][Full Text] [Related]
14. Association between interleukin-4 polymorphisms and environment and nonsmall cell lung cancer in Chinese population.
Gu J; Shen Y; Zhang Y
J Cancer Res Ther; 2014 Nov; 10 Suppl():C135-9. PubMed ID: 25450271
[TBL] [Abstract][Full Text] [Related]
15. IL1B gene polymorphisms, age and the risk of non-small cell lung cancer in a Chinese population.
Li Y; Zhao W; Zhao Z; Wu J; Chen L; Ma Y; Li Q; Lu D; Jin L; Wang J
Lung Cancer; 2015 Sep; 89(3):232-7. PubMed ID: 26141218
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D receptor genetic variants are associated with chemotherapy response and prognosis in patients with advanced non-small-cell lung cancer.
Xiong L; Cheng J; Gao J; Wang J; Liu X; Wang L
Clin Lung Cancer; 2013 Jul; 14(4):433-9. PubMed ID: 23522953
[TBL] [Abstract][Full Text] [Related]
17. Associations of polymorphisms in DNA repair genes and MDR1 gene with chemotherapy response and survival of non-small cell lung cancer.
Du Y; Su T; Zhao L; Tan X; Chang W; Zhang H; Cao G
PLoS One; 2014; 9(6):e99843. PubMed ID: 24933103
[TBL] [Abstract][Full Text] [Related]
18.
Li M; Chen R; Ji B; Fan C; Wang G; Yue C; Jin G
Ther Adv Respir Dis; 2020; 14():1753466620918192. PubMed ID: 32401173
[TBL] [Abstract][Full Text] [Related]
19. [A study on the relationship between endoplasmic reticulum aminopeptidase2 genetic polymorphisms and non-small cell lung cancer in Yunnan Han population].
Zhou J; Ma Q; Guo C; Shi L; Yao Y; Yu J; Zhang X
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Dec; 37(12):909-14. PubMed ID: 25609128
[TBL] [Abstract][Full Text] [Related]
20. RASSF1A, RECK genotypes and haplotypes in Egyptian population with Hepatocellular carcinoma.
Abd-Elfatah G; Gad-Allah AN
Immunol Lett; 2016 May; 173():36-41. PubMed ID: 26921475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
